Moxifloxacin vs Tofacitinib
Moxifloxacin vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Moxifloxacin and Tofacitinib.
Mechanism of Action
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Moxifloxacin β 12 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Moxifloxacin β C21H24FN3O4; Tofacitinib β C16H20N6O.
Molecular Weight: Moxifloxacin β 401.4350 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Moxifloxacin β Small molecule; Tofacitinib β Small molecule.